NCT01371682View on ClinicalTrials.gov

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 18, 2009

Primary Completion Date

December 2, 2009

Study Completion Date

December 2, 2009

Conditions

Parkinson Disease

Interventions

DRUG

Ropinirole XL

Ropinirole XL manufactured at Crawley will be compared to that manufactued at Aranda.

Trial Locations (1)

2060

GSK Investigational Site, Antwerp

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY